THR-317

· ThromboGenics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for THR-317, covering 2018-04-17 to 2020-09-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1) [Phase 2]